Hess ML, Okabe E, Poland J, Warner M, Stewart JR, Greenfield LJ. Jonassen AK, Aasum E, Riemersma RA, Mjos OD, Larsen TS. Johnston DL, Lewandowski ED. Fatty acid metabolism and contractile Kobayashi K, Neely JR. Mechanism of pyruvate dehydrogenase activa-

13. Demaison L, Moreau D, Vergely-Vandriesse C, Grégoire S, Degois M, Rochette L. Effects of dietary polyunsaturated fatty acids and hepatic steatosis on the functioning of isolated working rat heart under normoxic conditions and during post-ischemic reperfusion. Mol Cell Biochem 224: 103–116, 2001.

14. Dennis SC, Hearse DJ, Coltart DJ. A model for the generation of sponta-

neous yet predictable ventricular arrhythmias. Eur J Cardiol 12: 377–389, 1981. 15. Díaz R, Paolasso EA, Piegas LS, Tajer CD, Moreno MG, Corvalán R, Isea JE, Romero G. Metabolic modulation of acute myocardial infarc- tion. The ECLA Estudios Cardiologicos LatinoAmerica Collaborative Group. Circulation 98: 2227–2234, 1998. 16. Dobsak P, Courderot-Masuyer C, Zeller M, Vergely C, Laubriet A, Assem M, Eicher JC, Teyssier JR, Wolf JE, Rochette L. Antioxidative properties of pyruvate and protection of the ischemic rat heart during cardioplegia. J Cardiovasc Pharmacol 34: 651–659, 1999.

17. Doenst T, Bothe W, Beyersdorf F. Therapy with insulin in cardiac surgery:

controversies and possible solutions. Ann Thorac Surg 75: S721–S728, 2003.

18. Elvenes OP, Korvald C, Irtun O, Larsen T, Sorlie D. Both glucose-

insulin-potassium and glutamine in warm blood cardioplegia increase the rates of myocardial glucose and free fatty acid oxidation. Scand Cardio- vasc J 36: 19 –26, 2002.

19. Flood A, Hack BD, Headrick JP. Pyruvate-dependent preconditioning

and cardioprotection in murine myocardium. Clin Exp Pharmacol Physiol 30: 145–152, 2003.

20. Forsyth GW, Nagasawa HT, Alexander CS. Ethanol metabolism by the rat

heart and alcohol dehydrogenase activity. Can J Biochem 54: 539 –545, 1976.

21. Gao F, Shi DW, Wang XM, Dong L, Wang YM, Ma XL. Effects of

glucose-insulin-potassium cocktail on cardiac myocyte death and post- ischemic recovery cardiac functional recovery: the critical role of insulin. Zhonghua Nei Ke Za Zhi 42: 148 –152, 2003.

22. Griffin JL, White LT, Lewandowski ED. Substrate-dependent proton

load and recovery of stunned hearts during pyruvate dehydrogenase stimulation. Am J Physiol Heart Circ Physiol 279: H361–H367, 2000.

23. Goodwin GW, Taegtmeyer H. Metabolic recovery of isolated working

rat heart after brief global ischemia. Am J Physiol Heart Circ Physiol 267: H462–H470, 1994. 24. Gralinski MR, Black SC, Kilgore KS, Chou AY, Mccormack JG, Lucchesi BR. Cardioprotective effects of ranolazine RS-43285 in the isolated perfused rabbit heart. Cardiovasc Res 28: 1231–1237, 1994. 25. Gutterman DD, Chilian WM, Eastham CL, Inou T, White CW, Marcus ML. Failure of pyruvate to salvage myocardium after prolonged ischemia. Am J Physiol Heart Circ Physiol 250: H114 –H120, 1986.

26. Hachida M, Ookado A, Nonoyama M, Koyanagi H. Effect of HTK

solution for myocardial preservation. J Cardiovasc Surg Torino 37: 269 –274, 1996.

27. Hess ML, Okabe E, Poland J, Warner M, Stewart JR, Greenfield LJ.

Glucose, insulin, potassium protection during the course of hypothermic global ischemia and reperfusion: a new proposed mechanism by the scavenging of free radicals. J Cardiovasc Pharmacol 5: 35–43, 1983. 28. Jonassen AK, Brar BK, Mjos OD, Sack MN, Latchman DS, Yellon DM. Insulin administered at reoxygenation exerts a cardioprotective effect in myocytes by a possible anti-apoptotic mechanism. J Mol Cell Cardiol 32: 757–764, 2000.

29. Jonassen AK, Aasum E, Riemersma RA, Mjos OD, Larsen TS.

Glucose-insulin-potassium reduces infarct size when administered during reperfusion. Cardiovasc Drugs Ther 14: 615–623, 2000.

30. Johnston DL, Lewandowski ED. Fatty acid metabolism and contractile

function in the reperfused myocardium. Multinuclear NMR studies of isolated rabbit hearts. Circ Res 68: 714 –725, 1991.

31. Kobayashi K, Neely JR. Mechanism of pyruvate dehydrogenase activa-

tion by increased cardiac work. J Mol Cell Cardiol 15: 369 –382, 1983. 32. Korb H, Hoeft A, Hunneman DH, Schraeder R, Wolpers HG, Wober W, Hellige G. Changes in myocardial substrate utilisation and protection of ischemic stressed myocardium by oxfenicine [S-4-hydroxyphenylg- lycine]. Naunyn Schmiedebergs Arch Pharmacol 327: 70 –74, 1984.

33. Korvald C, Elvenes OP, Myrmel T. Myocardial substrate metabolism

influences left ventricular energetics in vivo. Am J Physiol Heart Circ Physiol 278: H1345–H1351, 2000.

34. Ladisa JF, Krolikowski JG, Pagel PS, Warltier DC, Kersten JR.

Cardioprotection by glucose-insulin-potassium: dependence on K-ATP channel opening and blood glucose concentration before ischemia. Am J Physiol Heart Circ Physiol 287: H601–H607, 2004.

35. Langendorff O. Untersuchungen am überlebenden Saügetierherzen.